These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 3561445

  • 21. [Guillain-Barré syndrome and acute disseminated encephalomyelitis (ADEM)].
    Hamaguchi K.
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1301-7. PubMed ID: 9128388
    [Abstract] [Full Text] [Related]

  • 22. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome.
    Wanschitz J, Maier H, Lassmann H, Budka H, Berger T.
    Brain; 2003 Sep; 126(Pt 9):2034-42. PubMed ID: 12847075
    [Abstract] [Full Text] [Related]

  • 23. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J, Yuan J, Hao H.
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [Abstract] [Full Text] [Related]

  • 24. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD, Davidovich A, Feldman D, Sprinkle TJ, Arezzo J, Brosnan C, Calderon RO, Fossom LH, DeVries JT, DeVries GH.
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
    Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP.
    Ann Neurol; 1998 Apr; 43(4):427-34. PubMed ID: 9546322
    [Abstract] [Full Text] [Related]

  • 26. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome.
    Sharief MK, Ingram DA, Swash M.
    Ann Neurol; 1997 Jul; 42(1):68-73. PubMed ID: 9225687
    [Abstract] [Full Text] [Related]

  • 27. [The Guillain-Barré syndrome].
    Piradov MA, Lozhnikova SM, Sakharova AV, Liudkovskaia IG, Nikitin SS.
    Arkh Patol; 1994 Jul; 56(5):73-9. PubMed ID: 7535047
    [Abstract] [Full Text] [Related]

  • 28. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome.
    Geczy C, Raper R, Roberts IM, Meyer P, Bernard CC.
    J Neuroimmunol; 1985 Aug; 9(3-4):179-91. PubMed ID: 2410449
    [Abstract] [Full Text] [Related]

  • 29. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T.
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [Abstract] [Full Text] [Related]

  • 30. Passive transfer studies in Guillain-Barré polyneuropathy.
    Feasby TE, Hahn AF, Gilbert JJ.
    Neurology; 1982 Oct; 32(10):1159-67. PubMed ID: 6889701
    [Abstract] [Full Text] [Related]

  • 31. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.
    Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW.
    Ann Neurol; 1996 May; 39(5):625-35. PubMed ID: 8619548
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [Abstract] [Full Text] [Related]

  • 34. Axonal Guillain-Barré syndrome.
    Feasby TE.
    Muscle Nerve; 1994 Jun; 17(6):678-9. PubMed ID: 8196712
    [Abstract] [Full Text] [Related]

  • 35. [Antiglycolipid antibody in inflammatory neuropathy].
    Kusunoki S.
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP.
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.